Implantable cardioverter defibrillator for primary prevention in patients with non-ischemic cardiomyopathy in the era of novel therapeutic agents- meta-analysis

Overview of attention for article published in Frontiers in Cardiovascular Medicine, May 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 34,520 followers.

RT @jpcostabel: Seguimos indicando CDI en prevención primaria en pacientes con Miocardiopatias no isquemico necroticas? Este metaanalisis d…

RT @jpcostabel: Seguimos indicando CDI en prevención primaria en pacientes con Miocardiopatias no isquemico necroticas? Este metaanalisis d…

RT @jpcostabel: Seguimos indicando CDI en prevención primaria en pacientes con Miocardiopatias no isquemico necroticas? Este metaanalisis d…

RT @jpcostabel: Seguimos indicando CDI en prevención primaria en pacientes con Miocardiopatias no isquemico necroticas? Este metaanalisis d…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.